Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs
- PMID: 12103306
- DOI: 10.1016/S0140-6736(02)09299-1
Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs
Comment in
-
Fire-and-forget in prevention of coronary heart disease.Lancet. 2002 Dec 14;360(9349):1984; author reply 1984. doi: 10.1016/S0140-6736(02)11890-3. Lancet. 2002. PMID: 12493308 No abstract available.
Similar articles
-
In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?J Fam Pract. 2001 Nov;50(11):924. J Fam Pract. 2001. PMID: 11711002 No abstract available.
-
[The new debate on cholesterol: is the lowest level the best?].Lakartidningen. 1999 Feb 10;96(6):648-52. Lakartidningen. 1999. PMID: 10087815 Review. Swedish. No abstract available.
-
Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.Am J Cardiol. 2003 Mar 6;91(5A):11C-17C; discussion 17C-19C. doi: 10.1016/s0002-9149(03)00004-3. Am J Cardiol. 2003. PMID: 12646338 Clinical Trial.
-
A need to redefine the consensus on the use of statins in coronary heart disease prevention.Eur Heart J. 2000 Oct;21(19):1572-3. doi: 10.1053/euhj.2000.2387. Eur Heart J. 2000. PMID: 10988008 No abstract available.
-
[LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]].Nihon Rinsho. 2001 Mar;59 Suppl 3:416-21. Nihon Rinsho. 2001. PMID: 11347106 Review. Japanese. No abstract available.
Cited by
-
Lack of Awareness of Own Hypercholesterolemia or Statin Medication among Adult Statin Users in the United States: Prevalence and Patient Characteristics in a Repeated Cross-Sectional Study.Int J Environ Res Public Health. 2022 May 17;19(10):6099. doi: 10.3390/ijerph19106099. Int J Environ Res Public Health. 2022. PMID: 35627634 Free PMC article.
-
Higher baseline lipid levels amplify the benefit of secondary prevention therapy with statins in Chinese patients with acute coronary syndrome.J Int Med Res. 2020 Nov;48(11):300060520965848. doi: 10.1177/0300060520965848. J Int Med Res. 2020. PMID: 33138662 Free PMC article.
-
Evolution of lipid management guidelines: evidence might set you free.Can Fam Physician. 2014 Jul;60(7):612-7, e333-9. Can Fam Physician. 2014. PMID: 25022632 Free PMC article. Review.
-
Are the new guidelines for the use of lipid-lowering agents sound, and should their adoption be encouraged?Can J Hosp Pharm. 2014 May;67(3):246-9. doi: 10.4212/cjhp.v67i3.1363. Can J Hosp Pharm. 2014. PMID: 24970946 Free PMC article. No abstract available.
-
Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes.Can Fam Physician. 2013 Nov;59(11):1169-80. Can Fam Physician. 2013. PMID: 24235189 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
